SCHEMBL20117831

SCHEMBL20117831

NC(=O)c1ccc(-c2ccccc2Cc2cccnc2)cc1N[C@H]1CC[C@H](O)CC1

nearest known ligand 0.61

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 19/20 0.61
HSP90B1 P14625 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20117765 0.90 HSP90AA1 (0.54) HSP90AA1HSP90B1
SCHEMBL20117932 0.90 HSP90B1 (0.52) HSP90AA1HSP90B1
SCHEMBL20117820 0.85 HSP90B1 (0.52) HSP90AA1HSP90B1
SCHEMBL20117966 0.84 HSP90AA1 (0.49) HSP90AA1HSP90B1
SCHEMBL20117962 0.84 HSP90AA1 (0.51) HSP90AA1HSP90B1
SCHEMBL20117826 0.83 HSP90AA1 (0.54) HSP90AA1HSP90B1
SCHEMBL20117960 0.83 HSP90B1 (0.64) HSP90AA1HSP90B1
SCHEMBL20117933 0.82 HSP90B1 (0.51) HSP90AA1HSP90B1
SCHEMBL20117967 0.82 HSP90B1 (0.51) HSP90AA1HSP90B1
SCHEMBL24217586 0.81 HSP90AA1 (0.63) HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220024869-A1 GRP94 SELECTIVE INHIBITORS AND USES THEREOF UNIVERSITY OF KANSAS 2022-01-27 US disclosed
WO-2018081814-A1 GRP94 SELECTIVE INHIBITORS AND USES THEREOF UNIVERSITY OF KANSAS (US) 2018-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220024869-A1 GRP94 SELECTIVE INHIBITORS AND USES THEREOF GRPR, HSP90B1, HSPE1 HSP90AA1 9/4885HSP90B1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.